ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
61 432,41
1,04%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Constellation Pharmaceuticals Inc (CNST)

  7. Constellation Pharmaceuticals Inc (CNST) Actualités

CNST

Constellation Pharmaceut... (CNST)

Constellation Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CNST
DateHeureSourceTitreSymboleSociété
23/07/202122h28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
20/07/202100h45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNSTConstellation Pharmaceuticals Inc
19/07/202112h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNSTConstellation Pharmaceuticals Inc
15/07/202116h37Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNSTConstellation Pharmaceuticals Inc
15/07/202116h33Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:CNSTConstellation Pharmaceuticals Inc
15/07/202115h40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
15/07/202115h15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CNSTConstellation Pharmaceuticals Inc
15/07/202114h48Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
06/07/202122h11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
16/06/202123h21Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CNSTConstellation Pharmaceuticals Inc
11/06/202115h00GlobeNewswire Inc.Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of PelabresibNASDAQ:CNSTConstellation Pharmaceuticals Inc
04/06/202115h00GlobeNewswire Inc.Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual MeetingNASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202123h21Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202123h08Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202113h40GlobeNewswire Inc.Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSysNASDAQ:CNSTConstellation Pharmaceuticals Inc
02/06/202113h25Business WireMorphoSys to Acquire Constellation PharmaceuticalsNASDAQ:CNSTConstellation Pharmaceuticals Inc
31/05/202115h00GlobeNewswire Inc.Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
10/05/202113h00GlobeNewswire Inc.Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:CNSTConstellation Pharmaceuticals Inc
10/05/202112h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNSTConstellation Pharmaceuticals Inc
27/04/202117h30GlobeNewswire Inc.Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
23/04/202112h15Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
29/03/202121h15Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CNSTConstellation Pharmaceuticals Inc
08/03/202123h39Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:CNSTConstellation Pharmaceuticals Inc
24/02/202122h12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNSTConstellation Pharmaceuticals Inc
24/02/202113h00GlobeNewswire Inc.Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
24/02/202112h07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
19/02/202122h00GlobeNewswire Inc.Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
18/02/202116h00GlobeNewswire Inc.Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
16/02/202122h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
02/02/202121h22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNSTConstellation Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNST

Dernières Valeurs Consultées

EU
AI
Air Liquide
COIN
BTCUSD
Bitcoin
NYSE
KO
Coca Cola
EU
RNO
Renault
NASDAQ
MSFT
Microsoft
FTSE
UKX
FTSE 100
EU
GLE
Societe Generale
NYSE
MRK
Merck
EU
CAP
Capgemini
NASDAQ
NVDA
NVIDIA
EU
BEL20
Bel 20
EU
ML
Michelin
COIN
ETHUSD
Ethereum
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés